Facts & Figures

• Industry Profile
• Highly regulated Industry
• Disease Burden in Europe


• Key Challenges
• Improving Europe's competitiveness
• External trade and competitiveness
• Parallel trade


• R&D and Innovation
• EU Pharmaceutical Sector Inquiry
• The Innovative Medicines Initiative (IMI)
• Animal welfare: 3R's
• Intellectual Property Rights
• Innovation in healthcare is incremental


• EU Policies
• EU Funds for Healthcare and Innovation
• EU Pharmaceutical Package
• High Level Pharmaceutical Forum
• EU Healthcare Strategy


• Legislation
• Regulation on Advanced Therapies
• R.E.A.C.H
• Community Patent
• Clinical Trials Directive
• Biotech patent Directive


• Ethics
• Dialogue with...
• ... towards Healthcare Professionals
• ... towards Patient Organisations


• Corporate Responsibility
• Global Public Health
• Enviornment
• Industry's role and actions

AIMS

• Roadmap of Priorities: AIMS
• The Informed Patient
• Fighting Counterfeiting
• Coding & Identification
• Patient's WAIT indicator
• EU Pharmaceutical Forum
• Innovative Medicines Initiative (IMI)
• Intellectual Property Rights
• Parallel Trade
• Global Public Health

Publications

• Publications
• Healthcare Facts & Figures
• Position Papers
• Industry Reports
• Code of Practice
• Animal welfare: 3R's
• Medicines for Mankind
• Market Access Delays
• Contributions & Articles
• Economic & Social Affairs
• Legal Affairs
• Scientific, Technical & Regulatory Affairs

NewsRoom

• Press Releases


• Archives
• EFPIA YouTube Channel
• EFPIA Blog
• Press Information Kits
• Contributions & Articles
• Picture Library
• Glossary of terms

Events

• Events
• Past events:
• EMEA-EFPIA 'QbD' Application Workshop
• EMEA-EFPIA Workshop on Adaptive Designs in Clinical Trials
• EMEA-EFPIA Information Day 2009
• Public ICH Regional Meeting 2008

Tools

• Links
• Glossary of terms
• Sitemap
• Contact us